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Since Schrader (1) began to synthesize alkyl-
phosphates, a great many organo-phosphorus
compounds have been produced. As these are
cholinesterase inhibitors, some of them have been
used as insecticides and the most toxic ones are
regarded as potential war gases. A number of
them have been put to use in medicine, e.g., di-
iso-propoxy-phosphoryl fluoride (DFP) which
was synthesized by Saunders (2). This compound
has been used in the treatment of glaucoma, of
post-operative paralytic ileus, and of myasthenia
gravis.
Although glaucoma patients often use eye-
drops containing DPF for daily conjunctival
instillation for months and even years, only few
reports on allergic reactions to such drops have
so far been published. Stone (3) observed two
patients with sensitivity to DFP in which "cu-
taneous tests" were positive to the drug in pea-
nut oil and negative to the vehicle. He also refers
to a ease reported by Guerry with the same re-
sponse to "cutaneous tests." In other reports on
presumed hypersensitivity to DFP, no epicu-
taneous testing seems to have been performed.
In addition to systemic side-effects of other
organo-phosphorus cholinesterase inhibitors, skin
reactions have also been reported (4). In these
reports, which only deal with the insecticide
group, hypersensitivity has in no case been dem-
onstrated on epicutaneous testing.
We have observed a patient with eczema of
the eye-lids associated with instillation of eye-
drops containing DFP. The hypersensitivity to
DFP was demonstrated by positive reaction on
epicutaneous testing. In order to establish a
possible group specificity of this hypersensitivity,
the patient was tested with some chemically
related compounds.
§ Presented at the Meeting of the Southwestern
Swedish Dermatologists, Gothenburg, May 27,
1961.
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CASE REPORT
Female, aged 63. Family history—Mother
urticaria, brother bronchial asthma. Previous
illnesses—No history of eczema or other allergic
diseases. Glaucoma for four years, topically
treated with a solution of pilocarpine and physo-
stigmine, and with Floropryl (0.1 per cent di-iso-
propoxy-phosphoryl fluoride in peanut oil, Merck
Sharp & Dohme) for the last year.
Present illness—At the first examination, the
patient presented an eczema of the right eyelid.
The eczema had developed slowly during the last
five months. It receded slowly after discontinuing
the use of the Floropryl drops, and on application
of a local hydrocortisone remedy. Routine epicu-
taneous patch testing was performed without any
positive reactions. The patient was also tested
with the eye-drops used, i.e., the pilocarpine-
physostigmine, and Floropryl. Only Floropryl
gave an eczematous reaction. Subsequent testing
with the two components of Floropryl* was per-
formed. An 1/10,000 dilution of DFP in olive oil
gave an eczematous reaction, while peanut oil
and olive oil gave no such reactions.
INVESTIGATION OF SENSITIVITY
In order to analyze the importance of the
fluorine atom and of the alkoxy groups for the
specificity of the hypersensitivity to DFP, the
patient was tested with compounds in which
these radicals had been substituted. As the de-
sired compounds were difficult to obtain, the
cross-sensitization pattern could not be com-
pletely analyzed. We succeeded in securing 17
compounds for the epicutaneous testing. § All
these compounds were applied in a concen-
tration of 1/10,000 in olive oil. When negative,
also a concentration of 1/1,000 was tried. Be-
cause of the high toxicity of methyl-iso-propoxy-
phosphoryl fluoride (Sarin), the highest test
concentration of this substance was 1/5,000.
Two drops (40 mg) were applied on the test patch.
* The supply of pure DFP and of peanut oil, by
Merck Sharp & Dohme, New York, U.S.A., is
gratefully acknowledged.§ The supply of compounds marked ++ in
table 1, by The Research Institute of National
Defence (Försvarets Forskningsanstalt), Stock-
holm, Sweden, and of compounds marked +, by
dr G. Schrader, Farbenfabriken Bayer, Germany,
is gratefully acknowledged.
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Not more than three compounds were tested
simultaneously. No cholinesterase inhibiting
effects were observed during the testings.
The test reactions are given in table 1.
In addition to DFP, diethoxy-phosphoryl
fluoride, iso-propoxy-üo-propyl-phosphoryl fluor-
ide and ethoxy-(dimethylamino)-phosphoryl fluor-
ide gave positive reactions. Thirteen com-
pounds showed negative reactions.
Testing with several compounds which gave
negative reactions but were chemically related
to the four allergenic substances made it possi-
ble to determine the main structural require-
ments for the cross-reactivity.
The organic phosphorus compounds are easily
hydrolyzed in the presence of water. It might be
assumed that the allergic reaction to .DFP was
caused by some of the hydrolyzation products
obtained through contact with the skin. How-
ever, a hydrolysate of DFP (table 1, b) con-
taining di-iso-propoxy-phosphate and hydro.
fluoric acid gave a negative reaction.
Testing with a compound in which fluorine in
DFP had been replaced by chlorine gave a nega-
tive reaction. Furthermore, the chloride, the
amide, and the cyanide (table 1, d) correspond-
ing to the allergenic diethoxy-phosphoryl fluor-
ide (table 1, e) gave negative reactions. Thus
the fluorine atom seems to be necessary for the
allergenicity.
In diethoxy-phosphoryl fluoride (table 1, e)
both alkoxy groups contain one carbon atom
less than those of DFP, yet a positive reaction
was obtained. Whether a compound with only
one carbon atom in each chain would give an
allergic reaction, could not be determined as the
corresponding dimethoxy compound was not
available. With four or more carbon atoms in
each chain (table 1, f) a negative reaction was
obtained. Thus the length of the alkoxy groups—
and through this the length of the whole mole-
cule—appears to determine the allergenic prop-
erties. This finding is in accordance with the
allergenic properties of certain diphenols which
show cross-sensitization (5).
When the alkyls are replaced by aromatic
nuclei (table 1, g) the allergenicity is lost.
Iso-propoxy-is o-propyl-phosphoryl fluoride
(table 1, h) gave a positive reaction. Thus it
was possible to exclude at least one oxygen atom
of the alkoxy group. A compound in which both
oxygen atoms were excluded was not available
for the present investigation. When the two
oxygen atoms are replaced by nitrogen, as in
di-iso-propylamino-phosphoryl fluoride (table 1,
i), the group specificity is lost.
Methyl-iso-propoxy-phosphoryl fluoride (table
1, j) yelded a negative reaction. This negative
reaction might be due either to the shortness of
one of the alkoxy groups or to the difference
in length between them.
Finally, ethoxy-(dimethylamino)-phosphoryl
fluoride (table 1, k) gave a positive reaction.
This compound, like iso-propoxy-iso-propyl-
phosphoryl fluoride (table 1, h), has slightly
asymmetric carbon chains, but the shortest chain
is longer than the methyl radical of the non-
allergenic methyl-iso-propoxy-phosphoryl fluor-
ide (table 1, j).It was not possible to clarify the importance
of the double-bound oxygen atom, as no com-
pound was available in which the oxygen had
been replaced by another element, e.g., sulfur.
CONCLUSIONS
The eyelid eczema of the patient had a clear
connection with the use of eye-drops containing
di-iso-propoxy-phosphoryl fluoride (DFP). The
hypersensitivity to the pure substance was dem-
onstrated by epicutaneous testing; there was no
hypersensitivity to compounds produced by hy-
drolysis.
The patient showed hypersensitivity to three
compounds chemically related to DFP. These
three compounds are synthetic and not in com-
mon use. Therefore, the patient cannot have had
contact with them before. For this reason a true
cross-sensitization with DFP as the primary
allergen is present.
In addition to the central phosphorus atom,
the structural requirements for cross-sensiti-
zation between these organo-phosphorus com-
pounds appear to be
1. a fluorine atom.
2. two symmetric or slighty asymmetric au-
phatic chains (alkyl, alkoxy or alkylamino
groups), each containing not more than three
carbon atoms.
3. an oxygen atom double-bound to the phos-
phorus atom.
There does not seem to be any relationship
between the requirements of molecular structure
for the allergenicity in this case and for the tox-
icity (6) of the compounds.
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TABLE 1
Compounds tested
a di-iso-propoxy-phosphoryl fluoride (DFP) (1/10,000) (CH3)2CH0 0 positive
(CH3)2CH0F
b di-iso-propoxy phosphate (hydro1ysate) (1/1,000) (CTL)2C110\/0 negative
(CH3)2CHO 0H
c di-iso-propoxy-phosphoryl ch1oride (1/1,000) (0113)2C110\/0 negative
(CH3)2CH0 Cl
d diethoxy-phosphoryl chIoride (1/1,000) C2HOO negative
C2H50 Cl
diethoxy-phosphoryl amide (1/1,000) C2H500 negative
C2H5/ \H2
diethoxy-phosphoryl cyanide (1/1,000) C2H500 negative
C2H50 CN
e diethoxy-phosphoryl fluoride (1/10,000) C2H50 0 positive
C2115 OF
I di- (ethoxy-ethoxy) -phosphoryl fluoride (1/1,000) C2H5 0 CH2 CH2 O\/O negative
C2H5OCH2CH2O F
di-n-hexoxy-phosphoryl fluoride (1/1,000) n—C6H13 00 negative
n—C6H130 F
di-n-octoxy-phosphoryl fluoride (1/1,000) nC8H1700 negative
n—C8H17O F
di-iso-octoxy-phosphoryl fluoride (1/1,000) i—CSH17O/O negative
i—C8H17O F
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TABLE 1—Continued
g di-cyclohexoxy-phosphoryl fluoride (1/1,000)
di- (4-methylcyclohexoxy) -phosphoryl fluoride
(1/1,000
h iso-propoxy-iso-propyl-phosphoryl fluoride (1/5,000)
i di-iso-propylamino-phosphoryl fluoride (1/1,000)
methyl-iso-propoxy-phosphoryl fluoride4 (1/5,000)
(Sarin)



























Epicutaneous allergy to the cholinesterase
inhibitor di- iso- propoxy-phosphoryl fluor-
ide (DFP) in a 63-year-old woman is described.
An eyelid eczema had developed from the use
of eye-drops containing DFP.
Cross-sensitization to diethoxy-phosphoryl
fluoride, to iso-propoxy-iso-propyl-phosphoryl
fluoride, and to ethoxy-(dimethylamino)-phos-
phoryl fluoride is demonstrated. The reactive
compounds constitute a new group of sub-
stances demonstrating cross-sensitization. The
structural requirements for the cross reactions
are discussed.
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